Compare AbCellera Biologics Inc (ABCL) vs SpaceX (SPCX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs SpaceX — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while SpaceX trades at $148.26 (market cap $1.97T). The key difference: SpaceX is far larger — about 838.3× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.
| ABCL | SPCX | |
|---|---|---|
Market Cap | $2.35B | $1.97T |
Sector | Health | Technology |
52-Week High | $8.12 | $202.09 |
52-Week Low | $2.78 | $135.00 |
Enterprise Value | $1.99B | $1.98T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPCX trades at $160.42, down 0.86% amid its Nasdaq-100 debut. Technical indicators are neutral, with support at $154 and resistance at $167. The company reported 2025 revenue of $18.67B but a net loss of $4.94B, with negative profit margins and high valuation multiples like P/S of 108.68. Recent news highlights inclusion in the Nasdaq-100 and analyst optimism, though earnings misses and cash burn from heavy investing raise concerns.
Outlook: Strong analyst consensus (100% buy, $240.80 target) reflects long-term growth faith in SpaceX's space economy role. However, persistent losses, high valuations, and execution risks in capital-intensive projects present significant downside. Investors face volatility from earnings uncertainty and competitive pressures, balancing speculative growth potential against fundamental weaknesses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
